▶ 調査レポート

抗凝固薬の世界市場レポート2020

• 英文タイトル:Global Anticoagulant Drugs Sales Market Report 2020

Global Anticoagulant Drugs Sales Market Report 2020「抗凝固薬の世界市場レポート2020」(市場規模、市場予測)調査レポートです。• レポートコード:20QY06-05510
• 出版社/出版日:QYResearch / 2020年6月3日
• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥540,000 (USD4,000)▷ お問い合わせ
  Multi User¥810,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,080,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、抗凝固薬のグローバル市場について種類別(NOAC、ヘパリン、ワルファリン、その他)、用途別(病院、薬局、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・抗凝固薬市場の概要
・世界の主要地域別抗凝固薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の抗凝固薬市場規模2015-2026:種類別(NOAC、ヘパリン、ワルファリン、その他)
・世界の抗凝固薬市場規模2015-2026:用途別(病院、薬局、その他)
・抗凝固薬の北米市場規模2015-2020
・抗凝固薬のヨーロッパ市場規模2015-2020
・抗凝固薬の中国市場規模2015-2020
・抗凝固薬の日本市場規模2015-2020
・抗凝固薬の東南アジア市場規模2015-2020
・抗凝固薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Bristol-Myers Squibb、Bayer、Pfizer、Johnson & Johnson、Sanofi、Boehringer Ingelheim、Daiichi Sankyo)
・抗凝固薬の製造コスト分析
・販売チャネル、流通業者、顧客
・抗凝固薬の市場動向・機会・課題
・調査の結論

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

Market Analysis and Insights: Global Anticoagulant Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anticoagulant Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anticoagulant Drugs industry.
Based on our recent survey, we have several different scenarios about the Anticoagulant Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 27110 million in 2019. The market size of Anticoagulant Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Anticoagulant Drugs Scope and Market Size
The global Anticoagulant Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anticoagulant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Anticoagulant Drugs market is segmented into
NOACs
Heparin
Warfarin
Others

Segment by Application, the Anticoagulant Drugs market is segmented into
Hospital
Pharmacy
Others

The Anticoagulant Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Anticoagulant Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Anticoagulant Drugs Market Share Analysis
Anticoagulant Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anticoagulant Drugs business, the date to enter into the Anticoagulant Drugs market, Anticoagulant Drugs product introduction, recent developments, etc.

The major vendors covered:
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo

レポート目次

1 Anticoagulant Drugs Market Overview
1.1 Anticoagulant Drugs Product Scope
1.2 Anticoagulant Drugs Segment by Type
1.2.1 Global Anticoagulant Drugs Sales by Type (2020-2026)
1.2.2 NOACs
1.2.3 Heparin
1.2.4 Warfarin
1.2.5 Others
1.3 Anticoagulant Drugs Segment by Application
1.3.1 Global Anticoagulant Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Anticoagulant Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anticoagulant Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Anticoagulant Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Anticoagulant Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Anticoagulant Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Anticoagulant Drugs Industry
1.5.1.1 Anticoagulant Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anticoagulant Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anticoagulant Drugs Players to Combat Covid-19 Impact

2 Anticoagulant Drugs Estimate and Forecast by Region
2.1 Global Anticoagulant Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anticoagulant Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anticoagulant Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Anticoagulant Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Anticoagulant Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anticoagulant Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anticoagulant Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anticoagulant Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Anticoagulant Drugs Estimates and Projections (2015-2026)
2.4.3 China Anticoagulant Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Anticoagulant Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anticoagulant Drugs Estimates and Projections (2015-2026)
2.4.6 India Anticoagulant Drugs Estimates and Projections (2015-2026)
3 Global Anticoagulant Drugs Competition Landscape by Players
3.1 Global Top Anticoagulant Drugs Players by Sales (2015-2020)
3.2 Global Top Anticoagulant Drugs Players by Revenue (2015-2020)
3.3 Global Anticoagulant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant Drugs as of 2019)
3.4 Global Anticoagulant Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Anticoagulant Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anticoagulant Drugs Players (Opinion Leaders)
4 Global Anticoagulant Drugs Market Size by Type
4.1 Global Anticoagulant Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Anticoagulant Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Anticoagulant Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Anticoagulant Drugs Price by Type (2014-2020)
4.2 Global Anticoagulant Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anticoagulant Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anticoagulant Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Anticoagulant Drugs Price Forecast by Type (2021-2026)
5 Global Anticoagulant Drugs Market Size by Application
5.1 Global Anticoagulant Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Anticoagulant Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Anticoagulant Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Anticoagulant Drugs Price by Application (2015-2020)
5.2 Global Anticoagulant Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anticoagulant Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anticoagulant Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anticoagulant Drugs Price Forecast by Application (2021-2026)

3 North America Anticoagulant Drugs Market Facts & Figures
3.2 North America Anticoagulant Drugs Sales Market Share by Company (2015-2020)
3.3 North America Anticoagulant Drugs Sales Market Share by Type (2015-2020)
3.4 North America Anticoagulant Drugs Sales Market Share by Application (2015-2020)

4 Europe Anticoagulant Drugs Market Facts & Figures
4.2 Europe Anticoagulant Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Anticoagulant Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Anticoagulant Drugs Sales Market Share by Application (2015-2020)

5 China Anticoagulant Drugs Market Facts & Figures
5.2 China Anticoagulant Drugs Sales Market Share by Company (2015-2020)
5.3 China Anticoagulant Drugs Sales Market Share by Type (2015-2020)
5.4 China Anticoagulant Drugs Sales Market Share by Application (2015-2020)

6 Japan Anticoagulant Drugs Market Facts & Figures
6.2 Japan Anticoagulant Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Anticoagulant Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Anticoagulant Drugs Sales Market Share by Application (2015-2020)

7 Southeast Asia Anticoagulant Drugs Market Facts & Figures
7.2 Southeast Asia Anticoagulant Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Anticoagulant Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Anticoagulant Drugs Sales Market Share by Application (2015-2020)

8 India Anticoagulant Drugs Market Facts & Figures
8.2 India Anticoagulant Drugs Sales Market Share by Company (2015-2020)
8.3 India Anticoagulant Drugs Sales Market Share by Type (2015-2020)
8.4 India Anticoagulant Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Anticoagulant Drugs Business
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Anticoagulant Drugs Corporation Information
12.1.2 Bristol-Myers Squibb Anticoagulant Drugs Business Overview and Total Revenue
12.1.3 Bristol-Myers Squibb Anticoagulant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol-Myers Squibb Anticoagulant Drugs Products Offered
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Bayer
12.2.1 Bayer Anticoagulant Drugs Corporation Information
12.2.2 Bayer Anticoagulant Drugs Business Overview and Total Revenue
12.2.3 Bayer Anticoagulant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Anticoagulant Drugs Products Offered
12.2.5 Bayer Recent Development
12.3 Pfizer
12.3.1 Pfizer Anticoagulant Drugs Corporation Information
12.3.2 Pfizer Anticoagulant Drugs Business Overview and Total Revenue
12.3.3 Pfizer Anticoagulant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Anticoagulant Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Anticoagulant Drugs Corporation Information
12.4.2 Johnson & Johnson Anticoagulant Drugs Business Overview and Total Revenue
12.4.3 Johnson & Johnson Anticoagulant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Anticoagulant Drugs Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Sanofi
12.5.1 Sanofi Anticoagulant Drugs Corporation Information
12.5.2 Sanofi Anticoagulant Drugs Business Overview and Total Revenue
12.5.3 Sanofi Anticoagulant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Anticoagulant Drugs Products Offered
12.5.5 Sanofi Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Anticoagulant Drugs Corporation Information
12.6.2 Boehringer Ingelheim Anticoagulant Drugs Business Overview and Total Revenue
12.6.3 Boehringer Ingelheim Anticoagulant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer Ingelheim Anticoagulant Drugs Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Daiichi Sankyo
12.7.1 Daiichi Sankyo Anticoagulant Drugs Corporation Information
12.7.2 Daiichi Sankyo Anticoagulant Drugs Business Overview and Total Revenue
12.7.3 Daiichi Sankyo Anticoagulant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Daiichi Sankyo Anticoagulant Drugs Products Offered
12.7.5 Daiichi Sankyo Recent Development

13 Anticoagulant Drugs Manufacturing Cost Analysis
13.1 Anticoagulant Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anticoagulant Drugs
13.4 Anticoagulant Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anticoagulant Drugs Distributors List
14.3 Anticoagulant Drugs Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Anticoagulant Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Anticoagulant Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Anticoagulant Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Anticoagulant Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Anticoagulant Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Anticoagulant Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Anticoagulant Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Anticoagulant Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Anticoagulant Drugs Revenue Share by Region (2015-2020)
Table 13. Global Anticoagulant Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Anticoagulant Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Anticoagulant Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Anticoagulant Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Anticoagulant Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Anticoagulant Drugs Sales Share by Company (2015-2020)
Table 19. Global Anticoagulant Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Anticoagulant Drugs Revenue Share by Company (2015-2020)
Table 21. Global Anticoagulant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant Drugs as of 2019)
Table 22. Global Anticoagulant Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Anticoagulant Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Anticoagulant Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Anticoagulant Drugs Players
Table 27. Global Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Anticoagulant Drugs Sales Share by Type (2015-2020)
Table 29. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Anticoagulant Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Anticoagulant Drugs Sales Share by Type (2021-2026)
Table 32. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Anticoagulant Drugs Revenue Share by Type (2021-2026)
Table 34. Global Anticoagulant Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Anticoagulant Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Anticoagulant Drugs Sales Share by Application (2015-2020)
Table 37. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Anticoagulant Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Anticoagulant Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Anticoagulant Drugs Sales Share by Application (2021-2026)
Table 41. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Anticoagulant Drugs Revenue Share by Application (2021-2026)
Table 43. Global Anticoagulant Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Anticoagulant Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Anticoagulant Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Anticoagulant Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Anticoagulant Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 56. China Anticoagulant Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 58. China Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 60. China Anticoagulant Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Anticoagulant Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Anticoagulant Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Anticoagulant Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 74. India Anticoagulant Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 76. India Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 78. India Anticoagulant Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Anticoagulant Drugs Product
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer Anticoagulant Drugs Product
Table 89. Bayer Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pfizer Anticoagulant Drugs Product
Table 94. Pfizer Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Anticoagulant Drugs Product
Table 99. Johnson & Johnson Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi Anticoagulant Drugs Product
Table 104. Sanofi Recent Development
Table 105. Boehringer Ingelheim Corporation Information
Table 106. Boehringer Ingelheim Description and Business Overview
Table 107. Boehringer Ingelheim Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Boehringer Ingelheim Anticoagulant Drugs Product
Table 109. Boehringer Ingelheim Recent Development
Table . Daiichi Sankyo Corporation Information
Table . Daiichi Sankyo Description and Business Overview
Table . Daiichi Sankyo Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Daiichi Sankyo Anticoagulant Drugs Product
Table . Daiichi Sankyo Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Anticoagulant Drugs Distributors List
Table 118. Anticoagulant Drugs Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulant Drugs Product Picture
Figure 2. Global Anticoagulant Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anticoagulant Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Others Examples
Figure 9. Global Anticoagulant Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Anticoagulant Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Anticoagulant Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Anticoagulant Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Anticoagulant Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Anticoagulant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Anticoagulant Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Anticoagulant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Anticoagulant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Anticoagulant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Anticoagulant Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Anticoagulant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Anticoagulant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Anticoagulant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Anticoagulant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Anticoagulant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Anticoagulant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Anticoagulant Drugs Players Market Share by Revenue in Anticoagulant Drugs 2015 & 2019
Figure 27. Anticoagulant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Anticoagulant Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Anticoagulant Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Anticoagulant Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Anticoagulant Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Anticoagulant Drugs Sales Market Share by Type in 2019
Figure 33. United States Anticoagulant Drugs Sales Market Share by Type in 2019
Figure 34. Europe Anticoagulant Drugs Sales Market Share by Company in 2019
Figure 35. Europe Anticoagulant Drugs Sales Market Share by Type in 2019
Figure 36. Europe Anticoagulant Drugs Sales Market Share by Application in 2019
Figure 37. China Anticoagulant Drugs Sales Market Share by Company in 2019
Figure 38. China Anticoagulant Drugs Sales Market Share by Type in 2019
Figure 39. China Anticoagulant Drugs Sales Market Share by Application in 2019
Figure 40. Japan Anticoagulant Drugs Sales Market Share by Company in 2019
Figure 41. Japan Anticoagulant Drugs Sales Market Share by Type in 2019
Figure 42. Japan Anticoagulant Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Anticoagulant Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Anticoagulant Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Anticoagulant Drugs Sales Market Share by Application in 2019
Figure 46. India Anticoagulant Drugs Sales Market Share by Company in 2019
Figure 47. India Anticoagulant Drugs Sales Market Share by Type in 2019
Figure 48. India Anticoagulant Drugs Sales Market Share by Application in 2019
Figure 49. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Anticoagulant Drugs
Figure 58. Manufacturing Process Analysis of Anticoagulant Drugs
Figure 59. Anticoagulant Drugs Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed